Neoadjuvant Treatment With Gemcitabine Plus Nab-Paclitaxel Versus Surgery First for Pancreatic Adenocarcinoma

HPB - United Kingdom
doi 10.1016/j.hpb.2018.06.2027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Performance Status Dynamics During Treatment With Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Metastatic Pancreatic Cancer

Cancer Management and Research
Oncology
2018English

A Granulocyte Colony-Stimulating Factor-Producing Pancreatic Adenocarcinoma Treated With Nab-Paclitaxel Plus Gemcitabine Chemotherapy

Suizo
2018English

Reply to the Comment on ‘Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Adenocarcinoma After Folfirinox Failure: An AGEO Prospective Multicentre Cohort’

British Journal of Cancer
Cancer ResearchOncology
2016English

Cost-Effectiveness Analysis Comparing FOLFIRINOX and Nab-Paclitaxel (Abaraxane) Plus Gemcitabine for First-Line Treatment of Patients With Metastatic Pancreatic Cancer From the US Societal Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Galunisertib Plus Gemcitabine vs. Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

The First Case of Drug-Induced Pseudoscleroderma and Eczema Craquelé Related to Nab-Paclitaxel Pancreatic Adenocarcinoma Treatment

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2018English

Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With Nab-Paclitaxel and Gemcitabine

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2017English

Inverse Probability of Treatment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocarcinoma With Arterial Abutment

Pancreatology
EndocrinologyHepatologyMetabolismGastroenterologyDiabetes
2017English

Nab-Paclitaxel: Potential for the Treatment of Advanced Pancreatic Cancer

OncoTargets and Therapy
OncologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy